Current updates and future perspectives on the management of renal cell carcinoma.

作者: Deepika Singh

DOI: 10.1016/J.LFS.2020.118632

关键词:

摘要: … for explicating the mechanism involved in nuclear function of CXCR4 and metastasis tumor [91]. … factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk …

参考文章(126)
Asim Amin, Elizabeth R. Plimack, Jeffrey R. Infante, Marc S. Ernstoff, Brian I. Rini, David F. McDermott, Jennifer J. Knox, Sumanta Kumar Pal, Martin Henner Voss, Padmanee Sharma, Christian K. Kollmannsberger, Daniel Yick Chin Heng, Jennifer L. Spratlin, Yun Shen, John F. Kurland, Paul Gagnier, Hans J. Hammers, Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients (pts) with metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology. ,vol. 32, pp. 5010- 5010 ,(2014) , 10.1200/JCO.2014.32.15_SUPPL.5010
Hari Koul, Sweaty Koul, Randall B Meacham, Fernando J Kim, Luiza Crompton, Kyle O Rove, Jung-Sik Huh, Molecular aspects of renal cell carcinoma: a review. American Journal of Cancer Research. ,vol. 1, pp. 240- 254 ,(2011)
Derek Atkins, Rudolf Lichtenfels, Barbara Seliger, Heat shock proteins in renal cell carcinomas. Contributions To Nephrology. ,vol. 148, pp. 35- 56 ,(2005) , 10.1159/000086042
Katherine A Murphy, Britnie R James, Yue Guan, Donald S Torry, Andrew Wilber, Thomas S Griffith, Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma Human Vaccines & Immunotherapeutics. ,vol. 11, pp. 1612- 1620 ,(2015) , 10.1080/21645515.2015.1035849
Go J. Yoshida, Hideyuki Saya, Therapeutic strategies targeting cancer stem cells. Cancer Science. ,vol. 107, pp. 5- 11 ,(2016) , 10.1111/CAS.12817
Sergei Kusmartsev, Evgeniy Eruslanov, Hubert Kübler, Timothy Tseng, Yoshihisa Sakai, Zhen Su, Sergei Kaliberov, Axel Heiser, Charles Rosser, Philip Dahm, Dietmar Siemann, Johannes Vieweg, Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma Journal of Immunology. ,vol. 181, pp. 346- 353 ,(2008) , 10.4049/JIMMUNOL.181.1.346
Matteo Santoni, Rossana Berardi, Consuelo Amantini, Luciano Burattini, Daniele Santini, Giorgio Santoni, Stefano Cascinu, Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitor. International Journal of Cancer. ,vol. 134, pp. 2772- 2777 ,(2014) , 10.1002/IJC.28503
Bruce F. Kimler, Jeffrey Holzbeierlein, Marsha Danley, Ossama W. Tawfik, Brandan Kramer, Barbara Shideler, Prognostic Significance of CD44, Platelet-Derived Growth Factor Receptor α, and Cyclooxygenase 2 Expression in Renal Cell Carcinoma Archives of Pathology & Laboratory Medicine. ,vol. 131, pp. 261- 267 ,(2007) , 10.1043/1543-2165(2007)131[261:PSOCPG]2.0.CO;2
Kathleen M. Mahoney, Paul D. Rennert, Gordon J. Freeman, Combination cancer immunotherapy and new immunomodulatory targets Nature Reviews Drug Discovery. ,vol. 14, pp. 561- 584 ,(2015) , 10.1038/NRD4591
Mohammed I. Khan, Anna M. Czarnecka, Igor Helbrecht, Ewa Bartnik, Fei Lian, Cezary Szczylik, Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells Stem Cell Research & Therapy. ,vol. 6, pp. 178- 178 ,(2015) , 10.1186/S13287-015-0177-Z